Dallah Health posts higher net profit at SAR 136.6m for 2013

31/12/2013 Argaam Exclusive

View other reports

Share Price

Dallah Healthcare Co.
168.40
2.20 1.32 %

Dallah Healthcare Co. (DALLAH HEALTH)

More

Dallah Health Holding Co., active in the operation and management of hospitals and medical clinics, reported SAR 136.6m net profit at the end of 2013, a 2.5% increase compared to last year, as shown in the following table:



Financials (M)

Item 2012 2013 Change‬
Revenues 636.86 749.65 17.7 %
Gross Income 286.87 327.45 14.1 %
Operating Income 130.75 137.53 5.2 %
Net Income 133.36 136.63 2.5 %
Average Shares 90.00 90.00 -
EPS (Riyals) 1.48 1.52 2.5 %


Current Quarter Comparison (M)

Compared With The
Item Q4 2012 Q4 2013 Change‬
Revenues 179.43 211.05 17.6 %
Gross Income 81.51 95.71 17.4 %
Operating Income 32.18 48.06 49.3 %
Net Income 34.37 52.11 51.6 %
Average Shares 90.00 90.00 -
EPS (Riyals) 0.38 0.58 51.6 %


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2004 - - - - - - -
Q2 2004 - - - - - - -
Q3 2004 - - - - - - -
Q4 2004 - - - - - - -
Q1 2005 - - - - - - -
Q2 2005 - - - - - - -
Q3 2005 - - - - - - -
Q4 2005 - - - - - - -
Q1 2006 - - - - - - -
Q2 2006 - - - - - - -
Q3 2006 - - - - - - -
Q4 2006 - - - - - - -
Q1 2007 - - - - - - -
Q2 2007 - - - - - - -
Q3 2007 - - - - - - -
Q4 2007 - - - - - - -
Q1 2008 - - - - - - -
Q2 2008 - - - - - - -
Q3 2008 - - - - - - -
Q4 2008 - - - - - - -
Q1 2009 - - - - - - -
Q2 2009 - - - - - - -
Q3 2009 - - - - - - -
Q4 2009 - - - - - - -
Q1 2010 - - - - - - -
Q2 2010 - - - - - - -
Q3 2010 104.78 - 36.90 - 17.82 - 0.20
Q4 2010 120.09 - 39.97 - 24.33 - 0.27
Q1 2011 129.97 - 49.69 - 35.25 - 0.39
Q2 2011 139.34 - 50.86 - 27.14 - 0.30
Q3 2011 115.44 10.2 % 37.37 1.3 % 15.49 (13.1 %) 0.17
Q4 2011 142.59 18.7 % 51.97 30.0 % 35.53 46.0 % 0.39
Q1 2012 154.04 18.5 % 72.82 46.5 % 37.96 7.7 % 0.42
Q2 2012 161.32 15.8 % 73.73 45.0 % 37.09 36.7 % 0.41
Q3 2012 142.26 23.2 % 59.00 57.9 % 23.94 54.5 % 0.27
Q4 2012 179.43 25.8 % 81.51 56.9 % 34.37 (3.3 %) 0.38
Q1 2013 183.73 19.3 % 84.40 15.9 % 39.04 2.8 % 0.43
Q2 2013 187.79 16.4 % 80.68 9.4 % 23.64 (36.3 %) 0.26
Q3 2013 167.08 17.4 % 66.67 13.0 % 21.84 (8.7 %) 0.24
Q4 2013 211.05 17.6 % 95.71 17.4 % 52.11 51.6 % 0.58
2013 749.65 17.7 % 327.45 14.1 % 136.63 2.5 % 1.52

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2004 - - -
Q2 2004 - - -
Q3 2004 - - -
Q4 2004 - - -
Q1 2005 - - -
Q2 2005 - - -
Q3 2005 - - -
Q4 2005 - - -
Q1 2006 - - -
Q2 2006 - - -
Q3 2006 - - -
Q4 2006 - - -
Q1 2007 - - -
Q2 2007 - - -
Q3 2007 - - -
Q4 2007 - - -
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 - - -
Q4 2009 - - -
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 35.90 % 22.84 % 21.15 %
Q3 2011 35.24 % 22.42 % 20.24 %
Q4 2011 36.01 % 24.05 % 22.15 %
Q1 2012 38.63 % 24.79 % 21.67 %
Q2 2012 41.14 % 25.88 % 22.58 %
Q3 2012 42.90 % 25.84 % 22.97 %
Q4 2012 45.06 % 25.05 % 20.93 %
Q1 2013 44.79 % 24.18 % 20.16 %
Q2 2013 44.08 % 22.36 % 17.45 %
Q3 2013 43.63 % 21.80 % 16.56 %
Q4 2013 43.68 % 23.30 % 18.23 %
2013 43.68 % 23.16 % 18.23 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2004 - - - -
Q2 2004 - - - -
Q3 2004 - - - -
Q4 2004 - - - -
Q1 2005 - - - -
Q2 2005 - - - -
Q3 2005 - - - -
Q4 2005 - - - -
Q1 2006 - - - -
Q2 2006 - - - -
Q3 2006 - - - -
Q4 2006 - - - -
Q1 2007 - - - -
Q2 2007 - - - -
Q3 2007 - - - -
Q4 2007 - - - -
Q1 2008 - - - -
Q2 2008 - - - -
Q3 2008 - - - -
Q4 2008 - - - -
Q1 2009 - - - -
Q2 2009 - - - -
Q3 2009 - - - -
Q4 2009 - - - -
Q1 2010 - - - -
Q2 2010 - - - -
Q3 2010 90.00 - - 3.67
Q4 2010 90.00 - - 3.94
Q1 2011 90.00 - - 4.29
Q2 2011 90.00 1.16 1.16 4.63
Q3 2011 90.00 1.14 1.14 4.80
Q4 2011 90.00 1.26 1.30 5.21
Q1 2012 90.00 1.29 1.33 5.66
Q2 2012 90.00 1.40 1.44 6.04
Q3 2012 90.00 1.49 1.53 6.31
Q4 2012 90.00 1.48 1.48 12.40
Q1 2013 90.00 1.49 1.49 12.83
Q2 2013 90.00 1.34 1.34 12.37
Q3 2013 90.00 1.32 1.32 12.64
Q4 2013 90.00 1.52 1.52 13.22

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2004 - - -
Q2 2004 - - -
Q3 2004 - - -
Q4 2004 - - -
Q1 2005 - - -
Q2 2005 - - -
Q3 2005 - - -
Q4 2005 - - -
Q1 2006 - - -
Q2 2006 - - -
Q3 2006 - - -
Q4 2006 - - -
Q1 2007 - - -
Q2 2007 - - -
Q3 2007 - - -
Q4 2007 - - -
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 - - -
Q4 2009 - - -
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 - - -
Q3 2011 - - -
Q4 2011 - - -
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 25.26 25.26 3.02
Q1 2013 23.15 23.15 2.70
Q2 2013 26.26 26.26 2.85
Q3 2013 26.93 26.93 2.82
Q4 2013 26.15 26.15 3.00

Business Segments (Million)

Compared With The
Period Medical Services Medicine and Pharmaceutical Products
Q1 2011 118.62 11.35
Q2 2011 132.76 6.58
Q3 2011 110.16 5.99
Q4 2011 134.16 7.73
Q1 2012 141.87 12.17
Q2 2012 148.75 12.57
Q3 2012 133.35 8.91
Q4 2012 163.03 16.20
Q1 2013 169.97 13.76
Q2 2013 168.24 19.56
Q3 2013 158.17 8.92
Q4 2013 192.80 18.25


Financial Ratios
Current
Market Cap (M Riyal) 16,449.31
Enterprise Value (EV) (M) 18,352.79
Shares Outstanding ((M)) 97.68
EPS ( Riyal) (TTM) 3.94
Book Value (BV) ( Riyal) 34.02
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 42.74
P/E (TTM) 42.74
Price/book 4.95
Return on Average Assets (%) (TTM) 6.2
Return on Average Equity (%) (TTM) 11.9
more

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.